TECOM Investments, a member of Dubai Holding, today announced that Dubai Healthcare City (DHCC), the world’s first integrated healthcare free zone, and Dubai Biotechnology and Research Park (DuBiotech), the major life sciences hub in the Middle East, will highlight new opportunities and showcase recent developments at Arab Health 2010, the region’s largest healthcare exhibition.
Running until 29 January at the Dubai International Convention and Exhibition Centre, the current edition of the show is expected to feature an expanded presence with over 2,600 exhibitors.
As a leader in providing the highest quality healthcare which prioritises patient needs, Dubai Healthcare City will launch a suite of new consultancy services including health informatics, medical licensing exams and Primary Source Verification, a system to verify the credentials, experience and qualifications of healthcare professionals. The services will aim to help the GCC healthcare organisations and professionals establish and maintain the highest quality standards that will benefit both the healthcare industry and the patient alike. In addition, DHCC will be highlighting new investment opportunities for leading healthcare providers interested in being part of one of the most ambitious healthcare developments in the world.
Dr. Ayesha Abdullah, Senior Vice-President of Dubai Healthcare City, said:
“Since its inception, DHCC has grown into a city of over 90 outpatient centers and diagnostic laboratories, 2 hospitals and over 100 commercial and retail services. We have the highest standards in healthcare and have received wide, international recognition for these standards.
As part of our continued focus on quality and meeting patient needs, we are expanding our services and investment opportunities. If organisations are committed to healthcare best practice and want to be a part of legacy that will change the face of healthcare in the region, they should visit us during Arab Health.”
Dr Marco Baccanti, Executive Director, DuBiotech, said: “Our participation at Arab Health 2010 comes close on the heels of the successful completion of the state-of-the-art Nucleotide Lab Complex. As the largest laboratory facility in the Middle East, it represents a major milestone in the development of DuBiotech. The complex is the ideal place to encourage life sciences initiatives where new ideas are conceptualised and developed into viable businesses.
“One of our business partners - MAQUET Middle East - has already commenced operations at the Lab Complex. Visitors to Arab Lab 2010 can look forward to viewing MAQUET’s revolutionary medical technology for operating room systems and intensive care units.”
DHCC is home to a wide range of national and international brands and provides a full range of medical services including: immunology, aesthesia, cardiology, dentistry, dermatology, ENT, endocrinology, family medicine, general surgery, internal medicine, neurology, obstetrics, ophthalmology, orthopaedic, physical therapy, plastic surgery, radiology, urology, among others. It is also emerging as a centre of excellence for Complementary and Alternative Medicine services, health informatics and health insurance.
Launched in 2005, the Dubai Biotechnology and Research Park, pursues a mission to create the biggest life sciences cluster in the Middle East. DuBiotech’s latest milestone includes the completion of the state-of-the-art four-storey Nucleotide Laboratory Complex. Comprising 256,000 sq. ft. of leasable area, the ultra-modern Nucleotide Lab Complex is designed to house biotech, life sciences and pharmaceutical activities ranging from research and development to diagnostic, analytical and equipment training activities.
The Arab Health Exhibition and Congress is supported by the UAE Ministry of Health, Dubai Health Authority and the Health Authority Abu Dhabi.
© 2000 - 2022 Al Bawaba (www.albawaba.com)